[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100636098":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":11,"centralContacts":20,"locations":11,"responsibleParty":26,"collaborators":11,"id":28,"slug":29,"hasResults":30,"nctId":31,"briefTitle":32,"officialTitle":32,"acronym":33,"eligibilityCriteria":34,"healthyVolunteers":30,"sex":35,"minAge":36,"maxAge":11,"enrollmentInfo":37,"targetDuration":11,"studyType":40,"phases":41,"briefSummary":43,"conditions":44,"keywords":46,"overallStatus":53,"whyStopped":11,"lastUpdateSubmitDate":54,"lastUpdatePostDateStruct":55,"startDateStruct":58,"completionDateStruct":60,"leadSponsor":62,"locationsCount":11},{"fullName":5,"class":6},"Acandis GmbH","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Implantation of SILANCE Stent \u002F Elimination of the lateral sinus stenosis","EXPERIMENTAL",null,[13],"Device: SILANCE Stent Implantation",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":11},"DEVICE","SILANCE Stent Implantation","Endovascular treatment of the lateral sinus stenosis is performed using the SILANCE stent with the aim of eliminating the stenosis and achieving resolution of the associated clinical symptoms.",[9],[21],{"name":22,"role":23,"phone":24,"phoneExt":11,"email":25},"Anna Gold","CONTACT","+49 7231 155000","info@acandis.com",{"type":27,"investigatorFullName":11,"investigatorTitle":11,"investigatorAffiliation":11,"oldNameTitle":11,"oldOrganization":11},"SPONSOR","100636098","stenting-of-symptomatic-cerebral-sinus-stenosis-with-the-lasercut-self-expanding-silance-stent-100636098",false,"NCT07561268","Stenting Of Symptomatic Cerebral siNus stenosIs With the laserCut Self-expanding SILANCE Stent","SONIC","Inclusion Criteria:\n\n* Diagnosis of idiopathic intracranial hypertension (IIH) according to the Modified Dandy Criteria.\n* Cerebrospinal fluid (CSF) lumbar puncture opening pressure \\> 25 cm H₂O.\n* Presence of lateral venous sinus stenosis confirmed by venous magnetic resonance angiography (MRA) or venous computed tomography angiography (CTA).\n* Presence of clinical symptoms consistent with IIH, including headaches, visual field loss, papilledema or pulsatile tinnitus.\n* Venous pressure gradient across the stenosis \\> 3 mmHg under general anaesthesia, \\> 4 mmHg under local anaesthesia.\n* Temporal Bone CT done for Patients suffering from Pulsatile Tinnitus\n* Written informed consent obtained prior to any study-related procedures.","ALL","18 Years",{"count":38,"type":39},99,"ESTIMATED","INTERVENTIONAL",[42],"NA","The objective of this clinical investigation is to evaluate and demonstrate the clinical benefit, performance, and safety of the SILANCE Stent, which is specifically designed for the treatment of patients with symptomatic sinus stenoses associated with IIH.",[45],"Idiopathic Intracranial Hypertension (IIH)",[47,48,49,50,51,52],"Symptomatic venous sinus stenosis","IIH","Sinus stenosis","Lateral Sinus Stenosis","Sinus Stenting","Idiopathic intracranial hypertension","NOT_YET_RECRUITING","2026-04-28",{"date":56,"type":57},"2026-05-01","ACTUAL",{"date":59,"type":39},"2026-09",{"date":61,"type":39},"2029-10",{"name":5,"class":6}]